a study on Glaucoma, Open-Angle High Blood Pressure
This study will evaluate the efficacy and safety of bimatoprost sustained-release (SR) in patients with open-angle glaucoma or ocular hypertension. The study includes a 12-month treatment period with an 8-month extended follow-up.
Glaucoma, Open-Angle Ocular Hypertension Bimatoprost Timolol
Open to people ages 18 years and up
This step makes sure spammers don’t flood our inbox
We will not share your information with anyone other than the team in charge of this study. Submitting your contact information does not obligate you to participate in research.
The study team should get back to you in a few business days.
You will also receive an email with next steps. Check your junk/spam folder if needed.
If you do not hear from the study team, please call 888-689-8273 and tell them you’re interested in study number NCT02250651.
© 2017 The Regents of the University of California